Association between overt, subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease using magnetic resonance imaging

BACKGROUND In addition to an elevated risk of cirrhosis and hepatocellular carcinoma, along with metabolic dysfunction-associated steatotic liver disease (MASLD) represents the primary contributor to chronic liver disease, affecting 30% of the global population. Hypothyroidism is a common disorder that may influence MASLD development. Limited data have addressed the association between the whole spectrum of hypothyroidism (overt, subclinical) and MASLD. AIM To determine the association between t